Healthcare company Rockwell Medical Inc (Nasdaq:RMTI) announced on Thursday that it has signed new distribution agreements with BioNuclear and Atlantic Medical International (AMI) in the Dominican Republic and Bermuda, anticipating USD1m in annual revenues related to these agreements.
In the Dominican Republic, a five-year distributor agreement with BioNuclear covers the import, sale and promotion of haemodialysis concentrates products. BioNuclear holds an option to extend the agreement for an additional five years.
In Bermuda, AMI will broaden its existing distribution of Rockwell Medical's products under an amended agreement.
These partnerships strengthen Rockwell Medical's presence and revenue streams in key markets.
Perrigo announces quarterly dividend
Valneva receives CEPI funding to boost access to world's first chikungunya vaccine
CVS Health announces quarterly dividend
Emmaus Life Sciences reports 2023 financial results
Quest Diagnostics to acquire LifeLabs from OMERS for USD1.35bn
Eli Lilly announces Q3 2024 dividend
Valneva's chikungunya vaccine IXCHIQ approved by Health Canada
AbbVie announces quarterly cash dividend
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline